BE2015C005I2 - - Google Patents

Download PDF

Info

Publication number
BE2015C005I2
BE2015C005I2 BE2015C005C BE2015C005C BE2015C005I2 BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2 BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 C BE2015C005 C BE 2015C005C BE 2015C005 I2 BE2015C005 I2 BE 2015C005I2
Authority
BE
Belgium
Application number
BE2015C005C
Other languages
French (fr)
Original Assignee
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/388,173 external-priority patent/US7270800B2/en
Priority claimed from US10/645,847 external-priority patent/US20050043523A1/en
Application filed by Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Univ Pittsburgh Commonwealth Sys Higher Education
Publication of BE2015C005I2 publication Critical patent/BE2015C005I2/fr

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/64—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2
    • C07D277/66—Benzothiazoles with only hydrocarbon or substituted hydrocarbon radicals attached in position 2 with aromatic rings or ring systems directly attached in position 2
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/60—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances involving radioactive labelled substances
BE2015C005C 2003-03-14 2015-01-27 BE2015C005I2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10/388,173 US7270800B2 (en) 2000-08-24 2003-03-14 Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
US10/645,847 US20050043523A1 (en) 2003-08-22 2003-08-22 Benzothiazole derivative compounds, compositions and uses

Publications (1)

Publication Number Publication Date
BE2015C005I2 true BE2015C005I2 (ja) 2023-03-07

Family

ID=35057877

Family Applications (1)

Application Number Title Priority Date Filing Date
BE2015C005C BE2015C005I2 (ja) 2003-03-14 2015-01-27

Country Status (16)

Country Link
EP (1) EP1611115B1 (ja)
JP (1) JP4875487B2 (ja)
CN (2) CN1784392A (ja)
AU (2) AU2004221897B2 (ja)
BE (1) BE2015C005I2 (ja)
BR (1) BRPI0408274B8 (ja)
CY (2) CY1113334T1 (ja)
DK (1) DK1611115T3 (ja)
ES (1) ES2393921T3 (ja)
HK (1) HK1086270A1 (ja)
HU (1) HUS1500006I1 (ja)
NO (3) NO330861B1 (ja)
PL (1) PL1611115T3 (ja)
PT (1) PT1611115E (ja)
RU (1) RU2440995C2 (ja)
SI (1) SI1611115T1 (ja)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7270800B2 (en) 2000-08-24 2007-09-18 University Of Pittsburgh Thioflavin derivatives for use in antemortem diagnosis of Alzheimer's disease and in vivo imaging and prevention of amyloid deposition
WO2002016333A2 (en) 2000-08-24 2002-02-28 University Of Pittsburgh Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
RU2371440C2 (ru) * 2004-05-20 2009-10-27 Дзе Скриппс Рисёч Инститьют Стабилизация транстиретина
GB0516564D0 (en) * 2005-08-12 2005-09-21 Ge Healthcare Ltd Fluorination process
BRPI0806785A2 (pt) * 2007-01-30 2011-09-13 Ge Healthcare Ltd ferramentas para auxiliar no diagnóstico de doenças neurodegenerativas
CN101293878B (zh) * 2007-04-25 2010-12-15 中国科学院上海应用物理研究所 苯并噻唑苯胺类化合物及其制备方法和应用
KR20110046503A (ko) * 2008-07-24 2011-05-04 지멘스 메디컬 솔루션즈 유에스에이, 인크. Ａｄ 병인을 확인하기에 유용한 영상화제
RU2518892C2 (ru) * 2008-09-23 2014-06-10 Виста Лабораториз Лтд. Лиганды для агрегированных молекул тау-белка
KR101770532B1 (ko) 2013-09-26 2017-08-22 에프. 호프만-라 로슈 아게 이미징 수단으로서의 이미다조[1,2-a]피리딘-7-아민
JP6260967B2 (ja) * 2013-11-06 2018-01-17 国立大学法人京都大学 放射性ヨウ素標識化合物、及び、これを含む放射性医薬
CN103613589B (zh) * 2013-11-29 2016-03-30 江苏华益科技有限公司 一种用于神经退行性疾病领域的新型pet显像剂前体及标准品的合成方法
SG11201701580XA (en) * 2014-08-29 2017-03-30 Chdi Foundation Inc Probes for imaging huntingtin protein
CN109400615B (zh) * 2017-08-18 2021-07-16 上海交通大学医学院附属新华医院 一种靶向β-淀粉样蛋白的香豆素类化合物及其制备与应用
GR1009516B (el) * 2018-03-22 2019-05-02 Εκεφε Δημοκριτος Τρικαρβονυλο-συμπλοκα μεταλλων μεταπτωσεως με βενζο-ετεροκυκλικο παραγωγο του κυκλοπενταδιενυλικου ανιοντος με υψηλη διαπερατοτητα του αιματοεγκεφαλικου φραγμου για εφαρμογες στη διαγνωση και θεραπεια νοσων του κνς

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL129477A0 (en) * 1996-11-22 2000-02-29 Elan Pharm Inc N-(aryl/heteroaryl)amino acid derivatives pharmaceutical compositions comprising same and methods for inhibiting beta-amyloid peptide release and/or its synthesis by use of such compounds
GB9919673D0 (en) * 1999-08-20 1999-10-20 Cancer Res Campaign Tech 2-Arlybenzazole compounds
WO2002016333A2 (en) * 2000-08-24 2002-02-28 University Of Pittsburgh Thioflavin derivatives and their use in diagnosis and theraphy of alzheimer's disease
JP2004524289A (ja) * 2000-12-22 2004-08-12 アストラゼネカ・アクチエボラーグ 治療化合物
WO2002085903A2 (en) * 2001-04-23 2002-10-31 The Trustees Of The University Of Pennsylvania Amyloid plaque aggregation inhibitors and diagnostic imaging agents
GB0229686D0 (en) * 2002-12-20 2003-01-29 Amersham Plc Solid-phase fluorination of benzothiazoles

Also Published As

Publication number Publication date
HUS1500006I1 (hu) 2015-02-18
RU2440995C2 (ru) 2012-01-27
AU2004221897A1 (en) 2004-09-30
PL1611115T3 (pl) 2013-01-31
BRPI0408274A (pt) 2006-03-21
CY1113334T1 (el) 2015-12-09
DK1611115T3 (da) 2012-11-26
NO2015005I1 (no) 2015-03-02
NO20054674D0 (no) 2005-10-11
RU2005131872A (ru) 2006-02-27
BRPI0408274B1 (pt) 2019-02-26
NO20054674L (no) 2005-12-13
JP2006522104A (ja) 2006-09-28
CY2015007I1 (el) 2015-12-09
EP1611115A1 (en) 2006-01-04
EP1611115B1 (en) 2012-08-22
HK1086270A1 (en) 2006-09-15
CN1784392A (zh) 2006-06-07
BRPI0408274B8 (pt) 2021-05-25
NO20110980L (no) 2005-12-13
AU2004221897A2 (en) 2004-09-30
CN102532055A (zh) 2012-07-04
PT1611115E (pt) 2012-12-07
SI1611115T1 (sl) 2012-12-31
NO330861B1 (no) 2011-08-01
CN102532055B (zh) 2016-05-11
AU2011200667A1 (en) 2011-03-10
AU2011200667B2 (en) 2011-12-22
ES2393921T3 (es) 2013-01-02
NO2015005I2 (no) 2015-02-18
JP4875487B2 (ja) 2012-02-15
AU2004221897B2 (en) 2010-11-18
AU2004221897A9 (en) 2009-08-20

Similar Documents

Publication Publication Date Title
BE2013C075I2 (ja)
BE2013C035I2 (ja)
BE2013C036I2 (ja)
BE2011C030I2 (ja)
JP2004167250A5 (ja)
JP2004145273A5 (ja)
JP2004094924A5 (ja)
BE2015C005I2 (ja)
JP2004088083A5 (ja)
BE2012C053I2 (ja)
JP2004140789A5 (ja)
JP2003314221A5 (ja)
JP2004029020A5 (ja)
JP2004080762A5 (ja)
JP2004031327A5 (ja)
JP2004209165A5 (ja)
JP2004227363A5 (ja)
AU2003207787A1 (ja)
AU2002331433A1 (ja)
AU2002348177A1 (ja)
AU2002362930A1 (ja)
AU2002316511A1 (ja)
AU2002318342A1 (ja)
AU2003207750A1 (ja)
AU2002333044A1 (ja)